Artikel ; Online: Two cancer stem cell-targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model.
Stem cells translational medicine
2020 Band 9, Heft 8, Seite(n) 821–826
Abstract: A key implication of the cancer stem cell model is that for a cancer therapy to be curative, it is imperative to eliminate the cancer stem cells (CSCs) that drive tumor progression. The California Institute for Regenerative Medicine is supporting two ... ...
Abstract | A key implication of the cancer stem cell model is that for a cancer therapy to be curative, it is imperative to eliminate the cancer stem cells (CSCs) that drive tumor progression. The California Institute for Regenerative Medicine is supporting two novel approaches that target CSCs, one an antibody-mediated immunotherapy targeting CD47 and the other an antibody targeting ROR1. This article summarizes the evidence that CSCs are targeted and discusses the results of early clinical trials within the context of the CSC model. |
---|---|
Mesh-Begriff(e) | Clinical Trials as Topic/standards ; Humans ; Immunotherapy/methods ; Neoplasms/therapy ; Neoplastic Stem Cells/pathology |
Sprache | Englisch |
Erscheinungsdatum | 2020-04-12 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article |
ZDB-ID | 2642270-0 |
ISSN | 2157-6580 ; 2157-6564 |
ISSN (online) | 2157-6580 |
ISSN | 2157-6564 |
DOI | 10.1002/sctm.19-0424 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.